PTCB Certified Pharmacy Technician (PTCE)Federal RequirementsHard
A pharmacy technician is performing a quality assurance check on prescriptions filled the previous day. They notice a prescription for Suboxone (buprenorphine/naloxone) for opioid dependence. What specific federal regulatory agency oversees the special prescribing requirements for this medication?
- AFood and Drug Administration (FDA)
- BDrug Enforcement Administration (DEA)
- CCenters for Disease Control and Prevention (CDC)
- DSubstance Abuse and Mental Health Services Administration (SAMHSA)
Show answer & explanationAnswer & explanation
Correct answer: D. Substance Abuse and Mental Health Services Administration (SAMHSA)
While Suboxone is a controlled substance regulated by the DEA, the specific prescribing requirements for buprenorphine products for opioid dependence, including the DATA 2000 waiver and subsequent changes, are primarily overseen by SAMHSA, through its Center for Substance Abuse Treatment (CSAT).
Why the other options are wrong
- A. The FDA approves medications for use but does not specifically oversee the prescribing requirements for opioid dependence treatment programs.
- B. The DEA regulates controlled substances in general, but SAMHSA specifically oversees the treatment requirements for buprenorphine for opioid dependence.
- C. The CDC focuses on public health, disease control, and prevention, not specific medication prescribing regulations for addiction treatment.
SAMHSA's Role in Buprenorphine Prescribing
The Substance Abuse and Mental Health Services Administration (SAMHSA) is the primary federal agency overseeing the regulations and requirements for prescribers of buprenorphine for opioid use disorder (OUD) treatment.
- Oversees the DATA 2000 Act (Drug Addiction Treatment Act).
- Responsible for X-Waiver (now largely removed) and other buprenorphine prescribing rules.
- Aims to expand access to OUD treatment.
- Works with DEA and FDA, but holds primary oversight for this specific area.
Memory trick: SAMHSA Saves Addicts, Manages Hopeful Solutions for Addiction.